In their position statement, the American Nurses Association (ANA) mentions that they’re “committed to eliminating health ...

B ERLIN -- Antibody-drug conjugates (ADCs) targeting Trop2 made a strong case as first-line standard of care for metastatic ...

RPT904 at both Q8W and Q12W dosing showed comparable efficacy and safety to omalizumab at Q4W dosing - Efficacy sustained at Week 16 after a single dose of RPT904 - Well tolerated with no serious ...

One of the most profound shifts in 2025 is one of definition. Agencies are expanding the definition of what "diverse-owned" means. While initially the emphasis was on Black-owned retailers, prompted ...

RAPT Therapeutics, Inc. ( NASDAQ: RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria October 20, 2025 8:30 AM EDT Good morning, and welcome to RAPT's conference ...

Ten years after the Paris Agreement, pension funds face a difficult question: can climate-aligned index investing still drive real-world change?

Sigma Lithium announces that it was included as a case study in a key industry report. The report "Climate and Nature Solutions in Brazil" was published by Instituto Itausa, an organization dedicated ...

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not ...

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed ...

From Crescent City to El Centro, Californians rally Oct. 18 against Trump-era policies in statewide ‘No Kings Day’ ...

Ken’s search for answers brought him to nearly a dozen doctors. After months of tests, he was finally diagnosed with a rare ...

A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...